Analysis of HIV-1 ENV host cell proteins by mass spectrometry method
Ended Awarded Last action
- Contract number
- HHSN27200003
- Awardee
-
International Aids Vaccine Initiative Inc. UEI ZEJBC8JQM3P5
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $508,433
Award facts
- Opportunity
-
- NIHAI2014013 Solicitation number
- Contract value 100% obligated
- $508,433.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- New York, NY 10004, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | $0 | |
| Other Administrative Action | -$145,595 | |
| Other Administrative Action | $0 | |
| Original award | $654,028 |
About this award
This federal contract award, valued at $508,433.00, was issued by the National Institute of Allergy and Infectious Diseases (NIAID) to the International AIDS Vaccine Initiative (IAVI), a global not-for-profit organization focused on developing HIV vaccines. The contract, which is not a set-aside, supports the analysis of HIV-1 envelope host cell proteins using mass spectrometry methods. IAVI serves as the prime contractor and has partnered with Biosciences Cellcarta Inc. (Caprion) as a subcontractor to provide specialized expertise in this area. The contract is part of IAVI's broader work, funded by various NIH institutes and other agencies, to advance the development of vaccines and antibodies for infectious diseases like HIV, tuberculosis, influenza, and Ebola. IAVI holds multiple IDIQ contracts with NIAID to provide a range of preclinical and translational services supporting biopharmaceutical product development.
Quick answers
Who was awarded contract HHSN27200003?
HHSN27200003 was awarded to International Aids Vaccine Initiative Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 21, 2016.
How much is contract HHSN27200003 worth?
The government has obligated $508,433 on HHSN27200003.
Is contract HHSN27200003 an order under another contract?
Yes. HHSN27200003 is a delivery order under HHSN272201600011I, an indefinite delivery contract.
Was contract HHSN27200003 competed?
The extent of competition for HHSN27200003 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award